Delivering paediatric precision medicine: Genomic and environmental considerations along the causal pathway of childhood neurodevelopmental disorders
Open Access
- 6 June 2022
- journal article
- review article
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 64 (9) , 1077-1084
Abstract
Precision medicine refers to treatments that are targeted to an individual's unique characteristics. Precision medicine for neurodevelopmental disorders (such as cerebral palsy, attention‐deficit/hyperactivity disorder, obsessive–compulsive disorder, Tourette syndrome, and autism spectrum disorder) in children has predominantly focused on advances in genomic sequencing technologies to increase our ability to identify single gene mutations, diagnose a multitude of rare neurodevelopmental disorders, and gain insights into pathogenesis. Although targeting specific gene variants with high penetrance will help some children with rare disease, this approach will not help most children with neurodevelopmental disorders. A ‘pathway’ driven approach targeting the cumulative influence of psychosocial, epigenetic, or cellular factors is likely to be more effective. To optimize the therapeutic potential of precision medicine, we present a biopsychosocial integrated framework to examine the ‘gene–environment neuroscience interaction’. Such an approach would be supported through harnessing the power of big data, transdiagnostic assessment, impact and implementation evaluation, and a bench‐to‐bedside scientific discovery agenda with ongoing clinician and patient engagement.What this paper adds: Precision medicine has predominantly focused on genetic risk factors. The impact of environmental risk factors, particularly inflammatory, metabolic, and psychosocial risks, is understudied. A holistic biopsychosocial model of neurodevelopmental disorder causal pathways is presented. The model will provide precision medicine across the full spectrum of neurodevelopmental disorders.Keywords
Funding Information
- Petre Foundation
- Financial Markets Foundation for Children
- National Health and Medical Research Council (APP1143767, APP1193648, APP1197940, APP1194940, APP1158954, GNT1158954)
This publication has 32 references indexed in Scilit:
- Maternal immune activation: Implications for neuropsychiatric disordersScience, 2016
- Single blind randomised controlled trial of GAME (Goals Activity Motor Enrichment) in infants at high risk of cerebral palsyResearch in Developmental Disabilities, 2016
- Concise Review: Stem Cell Interventions for People With Cerebral Palsy: Systematic Review With Meta-AnalysisStem Cells Translational Medicine, 2016
- Variation in cerebral palsy profile by socio‐economic statusDevelopmental Medicine & Child Neurology, 2015
- Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research dataThe Lancet, 2015
- Developmental vulnerability – don't investigate without a model in mindChild: Care, Health and Development, 2014
- Enriched Environments and Motor Outcomes in Cerebral Palsy: Systematic Review and Meta-analysisPediatrics, 2013
- Neurodevelopmental Genes Have Not Read The DSM Criteria: Or, Have They?Frontiers in Psychiatry, 2012
- Epigenetics and the Biological Definition of Gene × Environment InteractionsChild Development, 2010
- Ecology of the family as a context for human development: Research perspectives.Developmental Psychology, 1986